174 related articles for article (PubMed ID: 26934317)
61. Isolated tumor cells in lymph nodes are not a prognostic marker for patients with stage I and stage II colorectal cancer.
Lee MR; Hong CW; Yoon SN; Lim SB; Park KJ; Lee MJ; Kim WH; Park JG
J Surg Oncol; 2006 Jan; 93(1):13-8; discussion 18-9. PubMed ID: 16353185
[TBL] [Abstract][Full Text] [Related]
62. The prognostic impact of the log odds of positive lymph nodes in colon cancer.
Arslan NC; Sokmen S; Canda AE; Terzi C; Sarioglu S
Colorectal Dis; 2014 Nov; 16(11):O386-92. PubMed ID: 24980876
[TBL] [Abstract][Full Text] [Related]
63. Isolated tumor cells in regional lymph nodes as relapse predictors in stage I and II colorectal cancer.
Mescoli C; Albertoni L; Pucciarelli S; Giacomelli L; Russo VM; Fassan M; Nitti D; Rugge M
J Clin Oncol; 2012 Mar; 30(9):965-71. PubMed ID: 22355061
[TBL] [Abstract][Full Text] [Related]
64. Comparison of metastatic lymph node ratio staging system with the 7th AJCC system for colorectal cancer.
Zhang J; Lv L; Ye Y; Jiang K; Shen Z; Wang S
J Cancer Res Clin Oncol; 2013 Nov; 139(11):1947-53. PubMed ID: 24057646
[TBL] [Abstract][Full Text] [Related]
65. Log odds of positive lymph nodes: a novel prognostic indicator superior to the number-based and the ratio-based N category for gastric cancer patients with R0 resection.
Sun Z; Xu Y; Li de M; Wang ZN; Zhu GL; Huang BJ; Li K; Xu HM
Cancer; 2010 Jun; 116(11):2571-80. PubMed ID: 20336791
[TBL] [Abstract][Full Text] [Related]
66. Renal lymph nodes for tumor staging: appraisal of 871 nephrectomies with examination of hilar fat.
Mehta V; Mudaliar K; Ghai R; Quek ML; Milner J; Flanigan RC; Picken MM
Arch Pathol Lab Med; 2013 Nov; 137(11):1584-90. PubMed ID: 23651149
[TBL] [Abstract][Full Text] [Related]
67. [Oncological outcomes analysis of colorectal cancer with unfavorable histological features].
Lu JY; Xu L; Zhang GN; Sun XY; Qiu HZ; Wu B; Lin GL; Xiao Y
Zhonghua Wai Ke Za Zhi; 2018 Nov; 56(11):843-848. PubMed ID: 30392305
[No Abstract] [Full Text] [Related]
68. The integration of macroscopic tumor invasion of adjacent organs into TNM staging system for colorectal cancer.
Liang JW; Gao P; Wang ZN; Song YX; Xu YY; Wang MX; Dong YL; Xu HM
PLoS One; 2012; 7(12):e52269. PubMed ID: 23300631
[TBL] [Abstract][Full Text] [Related]
69. The impact of colorectal screening program on the detection of right-sided colorectal cancer. A 5-year cohort study in the Mantua District.
Asteria CR; Pucciarelli S; Gerard L; Mantovani N; Pagani M; Boccia L; Ricci P; Troiano L; Lucchini G; Pulica C
Int J Colorectal Dis; 2015 Dec; 30(12):1627-37. PubMed ID: 26255258
[TBL] [Abstract][Full Text] [Related]
70. Readjustment of nodal staging by integrating tumor deposits and positive lymph nodes in patients with stage III colon cancer: a population-based analysis.
Lin YH; Chen QX; Lu LB; Chen H; Wu JX; Wang XW; Chen YY; Lin Q; Li J; Chen X
Am J Cancer Res; 2023; 13(10):4976-4988. PubMed ID: 37970348
[TBL] [Abstract][Full Text] [Related]
71. Clinical and Pathologic Predictors of Tumor Deposits in Colorectal Cancer.
Jiang C; Shen Y; Xu C; Liu Y; Zhou H; Xu Q; Gu L
J Gastrointest Cancer; 2024 Mar; 55(1):182-187. PubMed ID: 38051392
[TBL] [Abstract][Full Text] [Related]
72. Tumor deposits in colorectal cancer: Refining their definition in the TNM system.
Ueno H; Nagtegaal ID; Quirke P; Sugihara K; Ajioka Y
Ann Gastroenterol Surg; 2023 Mar; 7(2):225-235. PubMed ID: 36998291
[TBL] [Abstract][Full Text] [Related]
73. What are the problems with the current staging of discontinuous tumour nodules (DTNs) in colorectal carcinoma? Is there a better way?
Karbanowicz E; Fuchs TL; Chou A; Sioson L; Sheen A; Ahadi MS; Gill AJ
Pathology; 2022 Dec; 54(7):848-854. PubMed ID: 36241558
[TBL] [Abstract][Full Text] [Related]
74. Extracapsular invasion as a risk factor for disease recurrence in colorectal cancer.
Fujii T; Tabe Y; Yajima R; Yamaguchi S; Tsutsumi S; Asao T; Kuwano H
World J Gastroenterol; 2011 Apr; 17(15):2003-6. PubMed ID: 21528079
[TBL] [Abstract][Full Text] [Related]
75. A nomogram improves AJCC stages for colorectal cancers by introducing CEA, modified lymph node ratio and negative lymph node count.
Zhang ZY; Gao W; Luo QF; Yin XW; Basnet S; Dai ZL; Ge HY
Sci Rep; 2016 Dec; 6():39028. PubMed ID: 27941905
[TBL] [Abstract][Full Text] [Related]
76. Clinical Impact of Histological Heterogeneity in the Metastatic Lymph Nodes of Patients with Colorectal Cancer.
Hirayama K; Sudoh M; Shimizu H; Furuya S; Akazawa Y; Iino H; Shiraishi K; Akaike H; Hosomura N; Kawaguchi Y; Amemiya H; Kawaida H; Inoue S; Kono H; Fujii H; Ichikawa D
Anticancer Res; 2018 Aug; 38(8):4797-4803. PubMed ID: 30061251
[TBL] [Abstract][Full Text] [Related]
77. The influence of nodal size on the staging of colorectal carcinomas.
Cserni G
J Clin Pathol; 2002 May; 55(5):386-90. PubMed ID: 11986347
[TBL] [Abstract][Full Text] [Related]
78. [Acetone treatment of lymph node preparations in staging colorectal specimens].
Richter D; Lorenz D; Isemer FE; Braun S; Fisseler-Eckhoff A
Pathologe; 2007 Jul; 28(4):269-72. PubMed ID: 17393170
[TBL] [Abstract][Full Text] [Related]
79. The value of tumor deposits in evaluating colorectal cancer survival and metastasis: a population-based retrospective cohort study.
Wu W; Zeng S; Zhang X; Liu P; Qiu T; Li S; Gong P
World J Surg Oncol; 2022 Feb; 20(1):41. PubMed ID: 35189906
[TBL] [Abstract][Full Text] [Related]
80. Serosal surfaces, mucin pools, and deposits, oh my: challenges in staging colorectal carcinoma.
Frankel WL; Jin M
Mod Pathol; 2015 Jan; 28 Suppl 1():S95-108. PubMed ID: 25560604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
